Skip to main content
Clinical Trials/CTRI/2019/04/018616
CTRI/2019/04/018616
Completed
未知

Comparative efficacy of routinely used two different concentrations of intranasal topical adrenaline and xylometazoline to reduce fiberoptic-guided nasotracheal intubation associated epistaxis - CETFONE

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: R00-R99- Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified
Sponsor
Sanjay Gandhi Postgraduate Institute of Medical Sciences
Enrollment
172
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
October 31, 2019
Last Updated
4 years ago
Study Type
Observational

Investigators

Eligibility Criteria

Inclusion Criteria

  • Male and female patients of age 18\- 65 years with American Society of Anaesthesiologists\- Physical Status Grade 1 and 2 posted with indication for nasotracheal intubation i.e. undergoing surgery involving oral cavity, mandible, maxilla, thyroid, neck, difficult airway with decreased mouth opening, cervical spine, etc

Exclusion Criteria

  • 1\) Patients who shall not give consent
  • 2\) Patients with nasal pathology (septal deviation, turbinate hypertrophy, nasal polyp and trauma)
  • 3\) Patients with history of common cold during prior 2 weeks or treatment with nasal decongestants, anti\-histamines, NSAIDS
  • 4\) Patients with coagulopathy and on anticoagulants
  • 5\) Patients with drug allergy, chronic pain syndrome, on analgesic medication
  • 6\) Pregnant patients

Outcomes

Primary Outcomes

Not specified

Similar Trials